Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383313248> ?p ?o ?g. }
- W4383313248 endingPage "104104" @default.
- W4383313248 startingPage "104104" @default.
- W4383313248 abstract "Previous studies demonstrate that the reformulation of OxyContin in the U.S. in 2010 induced substitution to illicit opioids, causing illicit opioid markets to grow disproportionately fast in states more exposed to the reformulation. In this paper, we examine if this shift to the illicit market also led to a rise in polysubstance overdose deaths involving non-opioid prescription drugs, including gabapentinoids and “Z-drugs” and, separately, benzodiazepines. Using a difference-in-differences framework, the relationship between exposure to reformulation and overdose death rates including specific substances was studied in each year from 1999 to 2020 while accounting for fixed differences across states, common nationwide shocks, and state-level differences in pain reliever misuse prior to reformulation. Exposure to reformulation was measured as the pre-reformulation rate of OxyContin misuse. Exposure to reformulation predicted growth in overdose deaths involving gabapentinoids and Z-drugs. There is less evidence that it predicted growth in overdose deaths involving benzodiazepines. However, for all substances, there is strong evidence that pre-reformulation OxyContin misuse rates predicted post-reformulation growth in overdose deaths concurrently involving synthetic opioids. The opioid crisis has changed in radical ways. This study links a major supply-side intervention to the increase in polysubstance overdose deaths involving non-opioid prescription drugs, specifically gabapentinoids and Z-drugs." @default.
- W4383313248 created "2023-07-07" @default.
- W4383313248 creator A5002919229 @default.
- W4383313248 creator A5056291685 @default.
- W4383313248 creator A5060939325 @default.
- W4383313248 date "2023-07-01" @default.
- W4383313248 modified "2023-10-16" @default.
- W4383313248 title "Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States" @default.
- W4383313248 cites W1632540777 @default.
- W4383313248 cites W1979997228 @default.
- W4383313248 cites W2008496020 @default.
- W4383313248 cites W2051089963 @default.
- W4383313248 cites W2089387135 @default.
- W4383313248 cites W2133712067 @default.
- W4383313248 cites W2151383246 @default.
- W4383313248 cites W2167551539 @default.
- W4383313248 cites W2273108584 @default.
- W4383313248 cites W2314214487 @default.
- W4383313248 cites W2469235540 @default.
- W4383313248 cites W2494765408 @default.
- W4383313248 cites W2566089772 @default.
- W4383313248 cites W2583970354 @default.
- W4383313248 cites W2584632369 @default.
- W4383313248 cites W2586087098 @default.
- W4383313248 cites W2763540422 @default.
- W4383313248 cites W2763928864 @default.
- W4383313248 cites W2790229981 @default.
- W4383313248 cites W2794011452 @default.
- W4383313248 cites W2794764561 @default.
- W4383313248 cites W2796033216 @default.
- W4383313248 cites W2808092861 @default.
- W4383313248 cites W2890727851 @default.
- W4383313248 cites W2909649480 @default.
- W4383313248 cites W2912770756 @default.
- W4383313248 cites W2924513576 @default.
- W4383313248 cites W2969815372 @default.
- W4383313248 cites W2974382724 @default.
- W4383313248 cites W2975621114 @default.
- W4383313248 cites W2990645485 @default.
- W4383313248 cites W2996755245 @default.
- W4383313248 cites W3005042045 @default.
- W4383313248 cites W3009920047 @default.
- W4383313248 cites W3029176155 @default.
- W4383313248 cites W3083304057 @default.
- W4383313248 cites W3088270938 @default.
- W4383313248 cites W3096987562 @default.
- W4383313248 cites W3098686935 @default.
- W4383313248 cites W3104589131 @default.
- W4383313248 cites W3110191235 @default.
- W4383313248 cites W3114704291 @default.
- W4383313248 cites W3158437926 @default.
- W4383313248 cites W3159801052 @default.
- W4383313248 cites W3160915496 @default.
- W4383313248 cites W3173873214 @default.
- W4383313248 cites W3181033293 @default.
- W4383313248 cites W3181426178 @default.
- W4383313248 cites W3194417040 @default.
- W4383313248 cites W3196353801 @default.
- W4383313248 cites W3206550053 @default.
- W4383313248 cites W3209395312 @default.
- W4383313248 cites W3212401906 @default.
- W4383313248 cites W4205092055 @default.
- W4383313248 cites W4206906981 @default.
- W4383313248 cites W4213176274 @default.
- W4383313248 cites W4213422094 @default.
- W4383313248 cites W4214864661 @default.
- W4383313248 cites W4226365853 @default.
- W4383313248 cites W4226432309 @default.
- W4383313248 cites W4280543883 @default.
- W4383313248 cites W4281777711 @default.
- W4383313248 cites W4283654315 @default.
- W4383313248 cites W4286218394 @default.
- W4383313248 cites W4308364835 @default.
- W4383313248 cites W4309509123 @default.
- W4383313248 doi "https://doi.org/10.1016/j.drugpo.2023.104104" @default.
- W4383313248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37422359" @default.
- W4383313248 hasPublicationYear "2023" @default.
- W4383313248 type Work @default.
- W4383313248 citedByCount "0" @default.
- W4383313248 crossrefType "journal-article" @default.
- W4383313248 hasAuthorship W4383313248A5002919229 @default.
- W4383313248 hasAuthorship W4383313248A5056291685 @default.
- W4383313248 hasAuthorship W4383313248A5060939325 @default.
- W4383313248 hasConcept C118552586 @default.
- W4383313248 hasConcept C121929971 @default.
- W4383313248 hasConcept C126322002 @default.
- W4383313248 hasConcept C170493617 @default.
- W4383313248 hasConcept C194828623 @default.
- W4383313248 hasConcept C2426938 @default.
- W4383313248 hasConcept C2776315796 @default.
- W4383313248 hasConcept C2778750930 @default.
- W4383313248 hasConcept C2779148768 @default.
- W4383313248 hasConcept C2779418921 @default.
- W4383313248 hasConcept C2781063702 @default.
- W4383313248 hasConcept C2911204551 @default.
- W4383313248 hasConcept C3017944768 @default.
- W4383313248 hasConcept C40010229 @default.
- W4383313248 hasConcept C71924100 @default.